CLINICAL STUDY OF PURGATION IN MIGRAINE BY TRIVRUT KALKA WITH KANJEE

A CLINICAL STUDY ON THE ROLE OF VIRECHANA KARMA BY TRIVRUT KALKA WITH KANJEE IN THE MANAGEMENT OF ARDHAVBHEDAKA

Status

Active, not recruiting

Phases

Phase 1Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012167

Enrollment

Registered

2018-02-26

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- patients comes under inclusive criteria of the study

Interventions

Intervention1: trivrut kalka with kanjee: Route of administration of the drug is oral and amount of Trivrut Kalka is 8O gm and Kanjee is 50 ml and duration of therapy is 8 days with follow up of 1 mon

Eligibility

Inclusion criteria

Inclusion criteria: Patients with symptoms of Ardhavbhedaka Vyadhi included like Manyaativedana Bhruativedana Sankhaativedana Karnaativedana Akshiativedana Ardhalalata ativedana

Exclusion criteria

Exclusion criteria: patients who are unable to convey their problem excluded patients above 60 years and below 16 years excluded patients who are contraindicated to do Virechan or in any serious illness

Design outcomes

Primary

Measure	Time frame
Patients relieve from all sign and symptoms of Ardhavbhedaka like pain in cervical and temporal region and in eye or ear in 1 monthTimepoint: 1 month duration of Assessment of results	—

Secondary

Measure	Time frame
observed all sign and symptoms of Ardhavbhedaka for 1 monthTimepoint: therapy duration is of 7 days, and complete treatment 1 month	—

Countries

India

Contacts

Public ContactDr Surendra Vedpathak

Bharati Ayurveda College and Hospital

drminaj362@gmail.com9960321732

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026